Assignee
IPSEN BIOPHARM LTD
GB·37 granted patents·65 pending applications·254 citations·filing 2006–2025
Top patents by PatentIndex Score
102 records- 0198US10722508B2Liposomes useful for drug deliveryIPSEN BIOPHARM LTD·Filed 2018·Granted Jul 28, 2020·11 cites·12 claims
- 0298US9737528B2Liposomes useful for drug delivery to the brainIPSEN BIOPHARM LTD·Filed 2016·Granted Aug 22, 2017·18 cites·1 claims
- 0397US11052079B2Liposomes useful for drug deliveryIPSEN BIOPHARM LTD·Filed 2017·Granted Jul 6, 2021·6 cites·8 claims
- 0497US9782349B2Liposomes useful for drug deliveryIPSEN BIOPHARM LTD·Filed 2015·Granted Oct 10, 2017·19 cites·17 claims
- 0597US9730891B2Liposomes useful for drug deliveryIPSEN BIOPHARM LTD·Filed 2015·Granted Aug 15, 2017·18 cites·20 claims
- 0697US9724303B2Liposomes useful for drug deliveryIPSEN BIOPHARM LTD·Filed 2015·Granted Aug 8, 2017·18 cites·20 claims
- 0797US9717724B2Methods for treating pancreatic cancer using combination therapiesIPSEN BIOPHARM LTD·Filed 2016·Granted Aug 1, 2017·14 cites·24 claims
- 0897US9717723B2Liposomes useful for drug deliveryIPSEN BIOPHARM LTD·Filed 2015·Granted Aug 1, 2017·18 cites·19 claims
- 0996US10980795B2Methods for treating pancreatic cancer using combination therapies comprising liposomal irinotecanIPSEN BIOPHARM LTD·Filed 2018·Granted Apr 20, 2021·8 cites·15 claims
- 1096US10413510B2Liposomes useful for drug deliveryIPSEN BIOPHARM LTD·Filed 2016·Granted Sep 17, 2019·12 cites·11 claims
- 1196US10350201B2Liposomes useful for drug deliveryIPSEN BIOPHARM LTD·Filed 2016·Granted Jul 16, 2019·12 cites·11 claims
- 1295US11844795B2Combination therapy for cancer treatmentIPSEN BIOPHARM LTD·Filed 2022·Granted Dec 19, 2023·2 cites·15 claims
- 1393US11369597B2Methods for treating pancreatic cancer using combination therapiesIPSEN BIOPHARM LTD·Filed 2018·Granted Jun 28, 2022·4 cites·13 claims
- 1493US10993914B2Stabilizing camptothecin pharmaceutical compositionsIPSEN BIOPHARM LTD·Filed 2019·Granted May 4, 2021·10 cites·36 claims
- 1593US10478428B2Combination therapy for cancer treatmentIPSEN BIOPHARM LTD·Filed 2017·Granted Nov 19, 2019·11 cites·17 claims
- 1693US10456360B2Stabilizing camptothecin pharmaceutical compositionsIPSEN BIOPHARM LTD·Filed 2016·Granted Oct 29, 2019·19 cites·31 claims
- 1792US9895365B2Combination therapy for cancer treatmentIPSEN BIOPHARM LTD·Filed 2016·Granted Feb 20, 2018·10 cites·20 claims
- 1891US10561604B2Pharmaceutical composition comprising botulinum, a non ionic surfactant, sodium chloride and sucroseIPSEN BIOPHARM LTD·Filed 2017·Granted Feb 18, 2020·10 cites·9 claims
- 1990US11344552B2Methods for treating metastatic pancreatic cancer using combination therapies comprising liposomal irinotecan and oxaliplatinIPSEN BIOPHARM LTD·Filed 2017·Granted May 31, 2022·4 cites·15 claims
- 2089US9757329B2Pharmaceutical composition comprising botulinum, a non ionic surfactant, sodium chloride and sucroseIPSEN BIOPHARM LTD·Filed 2015·Granted Sep 12, 2017·8 cites·18 claims
- 2189US2024226090A1Methods For Treating Pancreatic Cancer Using Combination Therapies Comprising Liposomal IrinotecanIPSEN BIOPHARM LTD·Filed 2024·Application pending·0 cites
- 2288US2024342162A1Methods For Treating Pancreatic Cancer Using Combination TherapiesIPSEN BIOPHARM LTD·Filed 2024·Application pending·0 cites
- 2387US11071726B2Treating gastric cancer using combination therapies comprising liposomal irinotecan, oxaliplatin, 5-fluorouracil (and leucovorin)IPSEN BIOPHARM LTD·Filed 2017·Granted Jul 27, 2021·6 cites·21 claims
- 2486US11318131B2Nanoliposomal irinotecan for use in treating small cell lung cancerIPSEN BIOPHARM LTD·Filed 2017·Granted May 3, 2022·3 cites·30 claims
- 2586US2025152578A1Stabilizing Camptothecin Pharmaceutical CompositionsIPSEN BIOPHARM LTD·Filed 2024·Application pending·0 cites
- 2686US2023181567A1Liposomes Useful for Drug DeliveryIPSEN BIOPHARM LTD·Filed 2022·Application pending·0 cites
- 2785US12059497B2Stabilizing camptothecin pharmaceutical compositionsIPSEN BIOPHARM LTD·Filed 2021·Granted Aug 13, 2024·1 cites·51 claims
- 2885US2026000666A1Methods For Treating Pancreatic Cancer Using Combination TherapiesIPSEN BIOPHARM LTD·Filed 2025·Application pending·0 cites
- 2984US7576181B2Method of administering porcine B-domainless fVIIIIPSEN BIOPHARM LTD·Filed 2006·Granted Aug 18, 2009·7 cites·24 claims
- 3083US2024358706A1Methods for Treating Metastatic Pancreatic Cancer Using Combination Therapies Comprising Liposomal Irinotecan and OxaliplatinIPSEN BIOPHARM LTD·Filed 2024·Application pending·0 cites
- 3182US12364691B2Methods for treating pancreatic cancer using combination therapiesIPSEN BIOPHARM LTD·Filed 2022·Granted Jul 22, 2025·0 cites·5 claims
- 3281US2025000796A1Stabilizing Camptothecin Pharmaceutical CompositionsIPSEN BIOPHARM LTD·Filed 2024·Application pending·0 cites
- 3379US2023108934A1Stabilizing Camptothecin Pharmaceutical CompositionsIPSEN BIOPHARM LTD·Filed 2022·Application pending·0 cites
- 3477US2021137914A1Liposomes Useful for Drug DeliveryIPSEN BIOPHARM LTD·Filed 2020·Application pending·0 cites
- 3577US2022096458A1Methods For Treating Pancreatic Cancer Using Combination Therapies Comprising Liposomal IrinotecanIPSEN BIOPHARM LTD·Filed 2021·Application pending·0 cites
- 3677US2025381191A1Methods for Treating Metastatic Pancreatic Cancer Using Combination Therapies Comprising Liposomal Irinotecan and OxaliplatinIPSEN BIOPHARM LTD·Filed 2025·Application pending·0 cites
- 3776US2024024415A1Treatment of lower limb spasticityIPSEN BIOPHARM LTD·Filed 2023·Application pending·0 cites
- 3875US2026021170A1Treatment of painIPSEN BIOPHARM LTD·Filed 2025·Application pending·0 cites
- 3975US2023062425A1Methods for Treating Metastatic Pancreatic Cancer Using Combination Therapies Comprising Liposomal Irinotecan and OxaliplatinIPSEN BIOPHARM LTD·Filed 2022·Application pending·0 cites
- 4074US12421284B2Chimeric neurotoxinsIPSEN BIOPHARM LTD·Filed 2022·Granted Sep 23, 2025·0 cites·20 claims
- 4174US12285468B2Liquid neurotoxin formulation stabilized with tryptophan or tyrosineIPSEN BIOPHARM LTD·Filed 2023·Granted Apr 29, 2025·0 cites·16 claims
- 4273US10648045B2Chimeric polypeptidesIPSEN BIOPHARM LTD·Filed 2016·Granted May 12, 2020·3 cites·12 claims
- 4373US2020179371A1Stabilizing Camptothecin Pharmaceutical CompositionsIPSEN BIOPHARM LTD·Filed 2019·Application pending·0 cites
- 4472US11066451B2Methods for purifying clostridial neurotoxinIPSEN BIOPHARM LTD·Filed 2016·Granted Jul 20, 2021·1 cites·16 claims
- 4570US11193931B2Cellular vamp cleavage assayIPSEN BIOPHARM LTD·Filed 2017·Granted Dec 7, 2021·1 cites·17 claims
- 4670US2021299213A1Treatment of lower limb spasticityIPSEN BIOPHARM LTD·Filed 2021·Application pending·0 cites
- 4770US2021228567A1Stabilizing Camptothecin Pharmaceutical CompositionsIPSEN BIOPHARM LTD·Filed 2020·Application pending·0 cites
- 4869US2023181702A1Liquid neurotoxin formulation stabilized with tryptophan or tyrosineIPSEN BIOPHARM LTD·Filed 2023·Application pending·0 cites
- 4968US2019262331A9Stabilizing Camptothecin Pharmaceutical CompositionsIPSEN BIOPHARM LTD·Filed 2018·Application pending·0 cites
- 5068US2025213662A1Bont/a for use in treating a facial dystoniaIPSEN BIOPHARM LTD·Filed 2023·Application pending·0 cites
Showing the top 50 of 102 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when IPSEN BIOPHARM LTD files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →